Merck
NYS:MRK
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
About
Pharmaceuticals: MajorFounded 1851
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines, which it sells to veterinarians, distributors and animal producers. The Alliances segment includes revenue from the company relationship with AstraZeneca LP. The Healthcare Services segment provides services and solutions that focus on engagement, health analytics and clinical services to improve the value of care delivered to patients. The company was founded in 1970 and is headquartered in Kenilworth, NJ.
Headquarters
Executives
Name | Title | Gender |
Mirian M. Graddick-Weir, PhD | Executive Vice President-Human Resources | Female |
Robert M. Davis, MBA | Chief Financial Officer & Executive Vice President | Male |
Kenneth C. Frazier | Chairman, President & Chief Executive Officer | Male |
Michael J. Holston | General Counsel & Executive Vice President | Male |
Teri Loxam | Vice President-Investor Relations | Female |
Clark Golestani | Chief Information Officer & Executive VP | Male |
Mindful Investing Summary
Merck - Competitors and Related Companies
How Merck stacks up to its peers in thePharmaceuticals: Major industry or with competing business segments.
Merck
NYS:MRK
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Bristol-Myers Squibb
NYS:BMY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Eli Lilly
NYS:LLY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Pfizer
NYS:PFE
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Roche
SWX:ROG-CH
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Sanofi
PAR:SAN-FR
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—